ECM degradation in AAAs occurs due to a chronic imbalance between elastolytic proteases (MMP2 and MMP9), generated by pro-inflammatory macrophages infiltrating the injured aorta wall, and their natural inhibitors, the TIMPs. This evidence concerns the gene MMP2 and achalasia-alacrima syndrome.